Factors Affecting Peripheral Blood Metrics and Their Impact on 30-Day Mortality in Pediatric Hemophagocytic Lymphohistiocytosis

Overview

This study investigates the impact of peripheral blood parameters on 30-day mortality risk in pediatric patients with hemophagocytic lymphohistiocytosis (HLH). It identifies significant predictors.

Background

Hemophagocytic lymphohistiocytosis (HLH) is a severe immune dysregulation syndrome in children, often leading to high mortality rates in the acute phase. Despite advancements in treatment, a significant proportion of patients still face early mortality due to complications. Understanding the role of peripheral blood parameters in predicting outcomes is crucial.

Data Highlights

Key Findings

• Red blood cell distribution width (RDW), mean corpuscular hemoglobin (MCH), hematocrit (HCT), and hemoglobin (Hb) were significantly associated with early mortality risk.
• The weighted quantile sum regression model indicated a significant joint protective effect of peripheral blood parameters against 30-day mortality risk (β = −0.936, P = 0.012).
• MCH and HCT exhibited the highest relative weights in predicting mortality risk.
• The area under the curve (AUC) of the combined predictive model improved to 0.728.
• Decision curve analysis confirmed the combined model's clinical net benefit across various threshold probabilities.

Clinical Implications

The findings indicate that abnormalities in peripheral blood parameters, particularly MCH and HCT, may serve as early warning indicators for mortality risk in pediatric HLH.

Conclusion

The study highlights the importance of peripheral blood metrics in predicting early mortality in pediatric HLH.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. Author(s)/Org, Source, Year -- Title
4. Author(s)/Org, Source, Year -- Title
5. Author(s)/Org, Source, Year -- Title
6. Author(s)/Org, Source, Year -- Title
7. Author(s)/Org, Source, Year -- Title
8. Contemporary diagnostic frameworks for pediatric hemophagocytic lymphohistiocytosis
9. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol
10. Predictive value of routine laboratory tests for early death in pediatric hemophagocytic lymphohistiocytosis patients - ScienceDirect